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Summary
The T cell receptor.(TCR)junctional regions (N regions) of the common human Vy9 and V62
gene segments were sequenced from the blood and lung of normal individuals (195 transcripts)
and a group of individuals with sarcoidosis (220 transcripts), a granulomatous disease in which
increased numbers of Vy9+ -y/b+ T cells are often observed. In normal individuals, the vast
majority (86%) ofblood Vy9 transcripts used the JyP gene segment. In contrast to this restriction
ofJ region usage, there was a large diversity of the junctional region, with <20% of blood
Vy9 junctional regions showing identical sequences for any one normal individual. For the blood
V62 transcripts in normal individuals, there was restriction of J region usage, with 93% using
J61. Thejunctional regions were even more diverse than for Vy9, with a unique sequence observed
in each transcript examined. Compared with blood, sequences from the normal lung showed
a small increase in identicaljunctional regions, particularly in.one individual where 46% of Vy9
transcripts examined were identical, suggesting a response of some y/6 T cells to antigens found
in the lung in the normal state. In marked contrast to normals, some individuals with sarcoidosis
had large numbers of Vy9 transcripts, as well as VS2 transcripts, sharing identical sequences.
For Vy9 blood transcripts, two individuals showed 84 and 56% ofjunctional region sequences
to be identical, respectively. Similarly, blood VS2 transcripts showed 43, 33, and 25% identical
junctional region sequences in three individuals. In the sarcoid patient with the most striking
over-representation of blood Vy9junctional sequences, lung Vy9 transcripts showed increased
(67%) use of the same junctional region sequence as in blood. This limited diversity of TCR
junctional regions among some individuals with sarcoidosis suggests a response from specific
stimuli, possibly antigenic, and that y/6 T cells may play a specific role in granuloma formation
in sarcoidosis, as has been suggested in other granulomatous diseases.
T lymphocytes recognize antigens through the TCR, a
CD3-associated heterodimeric surface complex that de-
fines the specificity of the T cell (1-3). In normal individ-
uals, most (>90%) ofblood T cells express a TCR composed
of a and 0 chains, proteins defined by a large repertoire of
genetic elements that recombine during T cell ontogeny, per-
mitting a broad diversity of antigen recognition (1-3) . The
remaining T cells have TCRs composed of y and 6 chains.
Although the TCRy/6 uses similar recombination processes,
unlike the broad repertoire ofgenetic elements that can poten-
tially define the TCRa/a, the human y/6 repertoires are
severely limited, with only eight functional Vy and five Jy
segments, and an even smaller number of V, D, and J seg-
ments defining the 6 locus (4, 5). Further, in normal indi-
viduals, the usage of TCR-y/6 appears to be even more re-
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stricted, in that >60% of blood y/6+ T cells use Vy9
elements, as detected by the mAb TiyA (6). In addition, anal-
ysis of Vy9+ T cell clones demonstrates that most TCRs
using Vy9 are Vy9JyP-Cy1 paired with a 6 chain using
the V62 elements (7, 8) . In this context, the diversity of the
TCR-y/6 is primarily based on the variable deletion or addi-
tion ofnucleotides to thejunctional regions (N regions) during
rearrangement of the y and 6 loci (9-11).
The reason for the increased representation and associa-
tion of these specific gene segments is not clear. In the con-
text that <5% of human postnatal thymic y/6+ clones have
this pattern of gene usage, it does not appear to result from
a restriction ofrecombinational possibilities at the gene level
nor a restriction of the protein pairing possibilities of 'Y and
6 chains (12). Rather, it is consistent with the concept that




169-181these cells are exported from the thymus during fetal devel-
opment and/or are subsequently expanded by restricted an-
tigenrecognition or other pressures. Further, put in the set-
ting of data suggesting that y/b+ T cells play a role in the
response to mycobacteria and parasites (13-18), and can
proliferate in response to mycobacterial heat shock proteins
(16-18), it is conceivable that theextensiveusageofVy9paired
with VS2 elements among normal blood y/b T cells may
reflect earlypost-thymic exposure to classes of antigens such
as heat shock proteins, or other developmental pressures to
expand T cells with such specificities.
The present study was designed to help understand these
concepts by evaluating the sequences of thejunctional seg-
ments of Vy9 and VS2 mRNA transcripts in normal indi-
viduals and from individuals with sarcoidosis. The relevance
of the sarcoidosis group relates to therecent observation that:
(a) 35% of individuals with sarcoidosis have increasednumbers
of y/b+ T cells, and >70% of these cells are TiyA+ (19); and
(b) sarcoidosis is asystemic granulomatous disorder forwhich
the etiology is unknown, but has long been considered to
relate in some fashionto mycobacteria and/or similar microor-
ganisms (20). By analyzing a total of 281 Vy9 transcripts
and134VS2transcripts ofnormals andindividuals with sar-
coidosis, we observed a broad diversity of Vy9 junctional
sequences in the normals, but a striking overrepresentation
of specific junctional region sequences in a subgroup of the
individuals with sarcoidosis. Further, thejunctional regions
o£VS2transcripts in thesesame sarcoid individuals also showed
an overrepresentation ofcertainsequences, although less than
with Vy9, suggesting the TiyA+ T cells observed in these
individuals areexpanded post-thymically in response to specific
pressures.
Materials and Methods
Source of T Lymphocytes.
￿
Two populations of individuals were
evaluated: normals and individuals with sarcoidosis. The normals
included nine individuals (referred to as "normal 1;' "normal 2;'
etc.; with the individual cDNA clones defined as N1. . , N2. . ,
respectively). Five individuals were used as asource ofbloodTcells
and four forlung Tcells. None had a history of lung disease, and
all hadnormal chestx-rays andlung function. Bronchoalveolarla-
vage of four normals showed a normal number of cells recovered
and normal cell differential (21). Thepatients with sarcoidosis in-
cluded five individuals diagnosedas previously described(22). All
had pulmonary sarcoidosis as diagnosedby an intrathoracicbiopsy
showing noncaseating granulomata. The average age was 38 ±
5 yr (all data arepresentedas mean ± SEM, andallstatistical com-
parisons were made using the two-tailed student's t test). There
were four malesandonefemale;threewere nonsmokers, twowere
ex-smokers. None was receiving therapy at the time of evaluation
or within the previous two mo. All had chest x-rays with diffuse
reticulonodular infiltrates and hilar adenopathy, and all had posi-
tive gallium-67 scans. Lung function tests (23) revealed vital ca-
pacity 64 ± 18% predicted, totallung capacity 79 t 6% predicted,
ratio of forced expiratory volume in 1 s to forced vital capacity
106 ± 10% predicted, anddiffusing capacity 66 ± 7% predicted.
As is typical for such individuals, bronchoalveolar lavage analysis
revealed an elevationof theaverage proportion oflymphocytes (37
± 11%) and the ratio of CD4' (helper/inducer T cells) to CD8'
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(suppressor/cytotoxic T cells) T cells (10.3 ± 6.5). The CD4'/
CD8' ratio for theblood T cells in the same individuals was 1.5
0.8 (24).
Blood mononuclear cellswere obtained from heparinized blood
by Ficoll-Hypaque (LSM; OrganonTeknika Corp., Durham, NC)
gradient centrifugation. Lung mononuclear cells were obtained from
bronchoalveolar lavage fluid as previously described (21). The
recovery of lung mononuclear cells was 15 ± 6 x 106 for the
normals and 63 ± 14 x 106 for the individuals with sarcoidosis.
mAbs and Flow Cytometry.
￿
Thephenotype of blood and lung
Tcellswas determined by two-colorimmunofluorescence andflow
cytometry (FRCS440; Becton Dickinson &Co., Mountain View,
CA) with themAbs Leu-4(CD3,panTcell, PE conjugated); Leu-3
(CD4, FITC conjugated); Leu-2 (CD8, FITC conjugated); TCR-1
(WT31, all a/a+ T cells, FITC conjugated) (25); (all these mAbs
were from Becton Dickinson & Co.); TCRS1 (all y/S' T cells,
FITC-conjugated; T Cell Sciences, Cambridge, MA) (26);TCS-61
(a V61/JSl determinant, 1`11C-conjugated, TCell Sciences) (27);
TiyA (recognizing a Vy9-encoded epitope of y/S+ Tcells; kindly
provided by T Hercend, Institut Gustave-Roussy, Villejuif, France)
(28). Indirect immunofluorescence wasperformedby usingFITC-
conjugated goat anti-mouse Ig (Becton Dickinson & Co.) as a
second antibody. Controlantibodies included isotype-matchedPE-
conjugated, FITC-conjugated, and unconjugated nonrelevant mouse
myelomaantibodies (control FITC, control PE, control Ig; Becton
Dickinson & Co.).
Analysis ofVy9 and V62 mRNA Transcripts.
￿
Totalcellular RNA
from bloodor lung mononuclear cells wasextracted usingtheguani-
dine/cesium chloride method (29). Briefly, thecells were lysed as
a pellet in 5.5 M guanidine isothiocyanate with 0.5% (vol/vol)
2-ME. Thelysateswere layered on acushionof5.7 M cesium chlo-
ride, 100mM EDTA, and theRNAwas collected aftercentrifuga-
tion (180,000 g, 12 h, 20°C) . Thepellet was dissolved in 10 mM
Tris-HCI, pH 7.4, 5 mM EDTA, and 1% SDS, precipitated with
ethanol, then redissolved in waterwith an RNaseinhibitor (RNasin;
PromegaBiotec, Madison, WI), andstored in liquid nitrogen vapor
until use. When small numbers of lymphocytes were evaluated,
as in thecase of the normal lung, cytoplasmic RNAwas extracted
as follows. Cells were suspended in 200 ul of 10 mM Tris-HCI,
pH 7.5, 10 mM NaCl, 3 MM MgCl2 with RNasin. Then, 20 Al
of 10% NP-40 was added. The mixture was vortexed, and after
centrifugation (12,000g, 5 min), the supernatant was recovered
andmixed with 200 Al of 1% SDS, 20 mM EDTA, pH 7.5, 0.6 M
NaCl, 20 mM Tris-HCI,pH 7.5. Afterphenol/chloroform extrac-
tion, RNA was ethanol precipitated.
To sequence Vy9 andVS2 mRNA transcripts in theblood and
lung T cell RNA preparations, the following strategy was used.
First-strand cDNA was synthesized from the extracted RNA by
usingcloned M-MLVreversetranscriptase (Bethesda Research Lab-
oratory Gaithersburg, MD) and oligo(dT) (1 h, 37°C). Aliquots
of the resulting mixture were used as template for amplification
by PCR with Taq DNA polymerase (Perkin-Elmer Cetus, Nor-
walk, CT) using the following primers: for Vy9, a Vy9 primer
with aPstl cutting site (PVG9; TATCTGCCAGGCACTGTCAGA-
AAGGAATC-3') andaCy primer with aSstI cutting site (PCG7;
5'-TAGAGCTCTATGTTCCAGCCTTCTGGAG-3'); and for VS2,
aVS2primer with aPstl site (PVD2:5'-GACTGCAGGAAGACC-
CAAGGTAACAC-3')andaCS primer (PCDI; 5'-GTTATCTTG-
GATGACACGAG-3'). The reaction was carried out in a 100-JAI
volume under recommended conditions for 45 cycles, consisting
of denaturation (94°C, 30 s); annealing (54°C, 30 s); and exten-
sion (72°C, 1 min) using a thermal cycler (Perkin-Elmer Cetus)
(30). Amplified products were phenol/chloroform extracted andethanol precipitated . After digestion of the Vy9 cDNA with Sstl
and PstI, and the V62cDNA with PstI and EcoRl (the amplified
CS region includes an EcoRl cutting sequence), respectively, the
cDNA was purified by 1.8% agarose gel electrophoresis, and the
appropriate sizedband wascut outandextracted (Geneclean ; Biol01,
LaJolla, CA). The digested, purified cDNA was ligated to M13mp19
plasmids, andplaques containing appropriate inserts were isolated
randomly. Sequencing wasdone by the dideoxy chain termination
method withT7DNApolymerase (Sequenase ; United States Bio-
chemical Corp., Cleveland, OH) and universal primer (31) .
Dot Blot Hybridization .
￿
To confirm the presence of multiple
copies of identical cDNAs in some individuals with sarcoidosis,
the relative numbersofspecificVy9-NJyPjunctional region tran-
scripts compared with total Vy9-NJy transcripts was evaluated
using allele-specific amplification, followed by dot blot hybridiza-
tion (32). After synthesis offirst-strandcDNA from theRNAprepa-
rations ofT cells ofnormalsand individuals with sarcoidosis, PCR
was performed with two sets of primers for 25 cycles under the
same conditions as describedabove . An allele-specific amplification
primer was constructed according to the specificjunctional region
sequence of the Vy9 gene (PVNJ9 ; 5'TACGTGGCCTTGTGG-
GAACGGGAA3'), identified as being present in abundance in some
individuals with sarcoidosis (see Results) . Two combinations of
primers were used for PCR amplification, PVG9 and PCG5 (5'-
CTGTCTTTATTGGAGGAAAGATAAT3'), and PVNJ9 and
PCG5 . The combination of PVG9-PCG5 will amplify all Vy9
mRNA transcripts, while the combination ofPVNJ9-PCG5 will
amplify only the cDNA that has the specificjunctional region se-
quence ofVy9mRNA transcripts. AmplifiedcDNAs were then
dot blotted on a nitrocellulose membrane, and-hybridized with a
'zP-labeled 274-bp Cy region cDNA probe . This probe was syn-
thesized by PCR using PCG2 (5'-AACAACTTGATGCAGATG-
TTTCC-3') and PCG3 (5'-TCATGTCTGACGATACATCTGTG-
3') and purified by electroelution (see Fig . 1) . The relative number
of Vy9 mRNA transcripts can then be compared visually.
Single CellAnalysis.
￿
For single cell analysis ofVy9mRNA tran-
scriptsfrom sarcoid 1, blood lymphocytes were stained with Leu-
4/PE and TCR-6l/FITC, and double positive cells (y/6 T cells)
were sorted byFRCS 440 so that each well of a 96-well U-shaped
plastic plate contained one cell (33) . RNA was then prepared as
described above, and Vy9 transcripts were amplified by PCR.
Results
FACS analysis of the blood and lung T cells of sarcoid in-
dividuals showed many with an increase in the proportion
ofy/6+T cells (y/S+/CD3+) in blood (47, 27, 23, 59, and
7% for sarcoids 1-5, respectively) . For all sarcoid individ-
uals, the proportions of y/S+ T cells in the lung was <10%,
although the increase in lung lymphocyte numbers in these
individuals resulted in a total increase in the number of -Y/b+
T cells in the lung compared with normals. Of the sarcoid
individuals with >10% y/6+ bloodT cells, several showed
an increase in TiyA+ T cells (TiyA+/CD3+: 38, 17, and
58%, for sarcoid 1, 2, and 4, respectively) . These same indi-
viduals had no relative increase in TCS-61+ blood T cells
(TCS-61+/CD3+ : 1, 11, and 1%, for sarcoid 1, 2, and 4,
respectively). Sarcoid3could notbe tested dueto insufficient
biologic material .
A totalof415mRNA transcripts were sequenced, including
281 Vy9 transcripts and 134 VS2 transcripts. For Vy9 tran-
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Figure 1.
￿
Germline sequences of the Vy9, Jy, VS2, D6, and J6
segments. At the top is a configuration of a. Vy9 cDNA (Vy9-NJy-
Cy), and below that is a configuration of a V62 cDNA (V62-N-Db-
NJ6-Cb) . The closed bar below each cDNA indicates the region se-
quenced . The primers used to amplify the cDNA for sequencing
were located at the 5' and 3' ends of the closed bars (primers PVG9
and PCG7 for Vy9; PVD2 and PCDI for V62 ; see Materials and
Methods) . Open bars indicate the sequences of Vy9 or V62 cDNAs,
as presented in Tables 1-6 . Below the diagrams of the cDNAs are the
germline sequences of the 3' portion ofVy9 and the 5' portion of 5
Jy gene segments (for the region shown, Jyl andJy2 are identical) .
Also shown are the 3' portion of V62, the 3 DS segments, and the
5' portion of 3J6 gene segments .
scripts, the region sequenced (see Fig. 1) included -100 by
of the 3' end of Vy9, the N region, the entire Jy region,
and -70by of the 5' endof theCy region . Becauseof space
limitations, only thejunctional regions are shown in the tables,
with the specific Jy segment identified . Likewise, -100 by
of the 3' end of VS2, the N region, Db region, N region,
entire J6 region, and -70 by of the 5' end of the CS region
were sequenced, but only thejunctional region is presented
in the tables, alongwith the specificJS region . Also, forboth
Vy9 and VS2 transcripts, the sequence is indicated as "in-
frame" (e.g., apotentially productive transcript based on se-
quence analysis) or not "in-frame" (e.g., likely a nonproduc-
tive transcript based on a frame shift such that theJy or J6
sequence did not correspond to a known genomic Jy or J6
sequence, respectively) (34-40).
Vy9 mRNA Transcripts in Blood T Cells of Normals.
￿
A
total of 81 Vy9 transcripts were evaluated in bloodT cells of
five individuals (Table 1) . Of these, 73 (90% ofall Vy9tran-
scripts) were in-frame (i .e., likely productive) sequences. Of the
73 clones with productive sequences, 63 clones (86%) used
theJyP gene segment, nine clones (12%) used Jy2, and one
clone(2%) usedJyl; no clones usedJyPI or Jy2 . Each normal
showed afew identicaljunctional sequencesused in more than
one transcript, butthe vast majority were different, showing
a large diversityin theV7-NJyjunctional region sequences.
Most ofthe identicaljunctional regions showed only a nucleo-
tide deletion of the 3' portion of the Vy9 gene segment or
the 5' portion of theJy gene segment with no addition ofTable 1.
￿
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Sequences shown include the 3' region of the Vy9 element (V), the N region, the 5' region of the Jy element (J), and the specific Jy element
(PY).
The clones were sequenced randomly, but for convenience, they are numbered so that identical sequences have consecutive numbers;
NIRG1-3, normal individual 1, blood T cells, y chain, clones 1, 2, and 3; NIB.G4, same but clone 4, etc.
t In-frame +, true mRNA transcript; -, nonproductive transcript based on sequence being frame shifted such that theJy region did not cor-






this sequence Clone V N J
Jy
region In-frame#
17 3 NIB .G1-3 GCCTTGTGGGAGGTG CAAGAOTTGGOC JP t
2 NlB.G4-5 (NrCTTGTOGGAG CAACTGG AAGAOTTGGOC JP
1 NIB .G6 GCCTTGTOGGA ACOGG AAGAOTTGGGC JP
1 NIB.G7 OCCTTGTOOGAGGT AGOC GAGTTGGGC JP
1 NSB .G8 OCCTTOTGOGAGG CAGGGGC AGAGTTG= JP
1 NiB .G9 GCCTTGTGOM40GT A CAAGAGTTGGOC JP
1 NlB.G10 GCCTTGTOGGAG CTTGTCC AAGAGTTGOOC JP
1 N1B .Gll GCCTTGTOGGAG CAG GAGTTGOGC JP
1 N1B.G12 GCCTTGTGGGAGGT A AAGAAA J1
1 N1B.G13 GCCTTGTGGGAGGT AAGGGAA AAG AA J2
1 NlB.G14 GCCTTGTOOGAGGTG CATTCTG ATTATAAGAM J2
1 NIB.G15 OCCTTOTGOGAGGT A AAGA A J2
1 NIB.G16 GCCTTGTOOGAGO COCOCTCCGG GAGTTOGW JP
1 NlB.G17 GCCTTGTGOQAGGT TCAGG TATAAGAAA Jl
16 2 N2B.G1-2 GCCTTGTOGGAGGTG CAAGAGTTGGOC JP +
1 N2B.G3 GCCTTOTGGGAOG C AGAGTTOOGC JP +
1 N2B.G4 GCCTTGTGGRiAGGT TCCCCGGGTTC TO= JP +
1 N2B.G5 GCCTTGTOOGAQGTG GOG GAGTTGOGC JP +
1 N28. G6 GCCTTGTGOGAGGTG CAG GAGTTOGC JP +
1 N2B.G7 GCCTTGTGGGAG CAATATCT GCAAGAGTTGOGC JP +
1 N2B.G8 GCCTTGTGOGA T CAAGAGTTGOGC JP +
1 N2B.G9 GCCTTGTOOGAGGTG AAT GAGTTGOOC JP +
1 N2B.G10 GCCTTGT CCGGAGACGC GCAAGAGTTGOOC JP +
1 N2B.Gll GCCTTGTGIXiAGGTG CCCGG AGAGTTOGGC JP +
1 N2B.G12 GCCTTOTOGGAGO AC AATTATTATAAOAAA J2 +
1 N2B.G13 GCCTTGTOGGA CCTGGGGGGAG ATTATTATAAGAM J2 +
1 N2B.G14 GCCTT AC ATTATTATAAGMA J2 +
1 N2B.G15 GCCTTGTGGGAOGTG TAATATC GCAAGAGTTOGGC JP -
1 92B.G16 GCCTTGTGGGAGGTG ACGG TATAAGAAA J2 -
13 2 N3B.G1-2 GCCTTGTGGGAGGTG CAAGAGTTGGGC JP +
1 N3B.G3 GCCTTGTGGGAGGTG AAC GAGTTOOOC JP +
1 N3B.G4 GCCTTGTGGGAG CGC GAGTTGGGC JP +
1 N3B.G5 GCCTTGTOOGA ATC AGAGTTGGGO JP +
1 N3B.G6 OCCTTGTGGGAGGTG CACTTG GAGTTGOOC JP +
1 N3B.G7 GCCTTGTGGGAGGT TGG AGAGTTGGGC JP +
1 N3B.G8 GCCTTGTGGGAG TTCC AGTTGGGC JP +
1 N3B .G9 GCCTTGTGGGAGG AACTG GAGTTGGGC JP +
1 N3B.G10 GCCTTGTGOGAGGT CCAC GAOTTOGOC JP +
1 N3B.G11 OCCTTGTOG TOC CAAGAGTTGOOC JP +
1 N3B.G12 GCCTTGTOGGAGGTG CGTOG GTTGGGC JP +
1 N3B.G13 GCCTTGTOOGAG AC GCAAGAGTTGOOC JP +
20 2 NOM-2 OCCTTGTOOGAOGTG CAAGAOTTGOGC JP +
1 N4B.G3 OCCTTOTOG GAOTTOGGC JP +
1 N4B.G4 OCCTTOTOG TGC CAAGAOTTGOOC JP +
1 N4B .G5 GCCTTGTOGGAOGTG TT AGAOTTOGOC JP +
1 N4B.GG GCCTTOTGOGAGO A GCAAOAGTTGOGC JP +
1 N4B .G7 GCCTTGTOGW ACT CAAGAGTTGWC JP +
1 N4B.G8 GCCTTGTGOG GGGCAOC GTTOOGC JP +
1 N4B.G9 GCCTTGTOGOAGGTG CACTTG GAGTTGGOC JP +
1 N4B.G10 GCCTTGTGGGAGGTG CACACCACCGCAACG GAGTTGGGC JP +
1 N4B .G11 GCCTTGTOOG TT CAAGAGTTOOGC JP +
1 N4B .G12 GCCTTGTGOGAGGTG TTOTCTA AGTTGGGC JP +
1 N4B .G13 GCCTTGTOGGAG CGTCTAGGGGG AGAOTTGGOC JP +
1 N4B .G14 OCCTTGTOM TAC AGAGTTG= JP +
1 N4B.G15 OCCTTGTGOGA ATC AGAOTTGGOC JP +
1 N4B .G16 GCCTTGTGOGAG TCCGCGGGG GAGTTGOGC JP +
1 N4B.G17 GCCTTGTGGGAG TTA CAAGAGTTGOGC JP +
1 N4B .G18 GCCTTGTGGGAGOTG CG AGAGTTGGOC JP +
1 N48 .G19 GCCTTOTGOOAOG GCCCGGCGA ATTATAAGAAA J2 +
1 N4B .G20 GCCTTOTGOGAOGT TGCGAAGG GAOTTGGGC JP -
15 2 NSB .G1-2 GCCTTGTOGGA ACGGG AAGAGTTGGOC JP +
1 N5B .G3 GCCTTGTOGGAGGTG CGGCG AGAGTTOGGC JP +
1 N5B .G4 GOGTTGTGGGAGGTG CATGAG GAGTTGOGC JP +
1 N5B.G5 GCCTTGTGOG TTGTCGACCAAC AGTTGGGC JP +
1 N5B.G6 GCCTTGTGGsAGGT AGGC GAGTTOGGC JP
1 N5B .G7 GCCTTGTOOGAGG GG GAGTTGGGC JP +
1 N58.G8 GCCTTGTGGGAGGTG COG GAGTTOGGC JP +
1 N5B .G9 GCCTTGTGGGAGGT TTC AGAGTTGGGC JP +
1 N5B.G10 GCCTTGTGOGAGGTG CAGTGG GAGTTGWC JP +
1 N5B.Gll GCCTTG TATTATAAGAAA J2 +
1 N5B .G12 GCCTTGTGGGAG CG TTATAAGAAA J2 +
1 N5B.G13 GCCTTGTOGGAGGTG CGGCGAG GAGTTGGGC JP -
1 NSB .G14 GCCTTGTGOGAGG GTAGGC GAGTTGGGC JP -
1 N5B .G15 GCCTTGTGGGAG(;TG ACGG TATAAGAAA J2 -nucleotides. One normal individual (normal 1) showed three
clones with the same Vy9functional sequence (5'-GCCTTG-
TGGGAGGTA3'; NlB.G9, NIRG12, NlRG15) but three
different Jy gene segments.
Vy9 tnRNA Transcripts in Lung T Cells ofNormals.
￿
A
total of64 Vy9 transcripts were analyzed in lung T lympho-
cytes of four normals (Table 2). Almost all (60 clones, 94%)
showed in-frame sequences. In general, the pattern of sequences
was similar to that in blood, with a large diversity among
the lung sequences. Of the lung Vy9 transcripts with in-
frame sequences, 37 clones (62%) used the JyP gene seg-
ment, 18 used Jy2 (30%), three used JyP2 (5%), two used
J-yPl (3%), and none usedJyl. Among each individual, most
sequences were unique, but more sequences shared the same
Table 2.
￿
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junctional regions than that observed in blood of normals.
The most striking example was normal 9, who showed six
transcripts out of 13 (46%; clones N9L.G1-6) with the same
sequence. However, for the other three individuals, at most,
19% (3 of 16, clones N6L.G1-3, normal 6), 16% (3 of 16,
clones N7LM-3, normal 7), or 14% (2 of 14 for three sets
of clones, normal 8) were identical. Taken together, of the
60 in-frame Vy9 sequences evaluated in the four normals,
the most that any one functional sequence was observed was
10% (six clones [N9L.G1-6] for normal 9); this sequence was
not observed in any other normal (lung or blood, Tables 1
and 2).
Vy9 mRNA Transcripts in Bloodand Lung T Cells ofIndi-
viduals with Sarcoidosis.
￿
For the individuals with sarcoidosis,
J'r
Sequences shown include the same regions described in Table 1.
' The clones are numbered in the same fashion as described in Table 1; N6L.G1-3, normal individual 6, lung T cells, -y chain, clones 1, 2,
and 3, etc.
t 16 by of the 5' portion of the Jy2 gene segment was deleted. See Fig. 1 for the location.
Individual sequences this sequence Clone' V N J region In-frame#
Normal 6 16 3 N6L .G1-3 GCCTTGTGGGA CGCGAG AAGAGTTGWC JP +
2 N6L .G4-5 GCCTTGTGGGAGGT A CAAGAGTTGGGC JP +
2 N6L .G6-7 GCCTTGTGGGAG AC GCAAGAGTTGGGC JP +
1 N6L .G8 GCCTTGTGGGAG CGGGAGCGGGCG GAGTTGGGC JP +
1 N6L .G9 GCCTTGTGGG GGGTGCACGGGC TGGGC JP +
1 N6L .G10 GCCTTGTGGCAGGT AGGC GAGTTGGGC JP +
1 N6L .G11 GCCTTGTGGG TAGATGGG GAGTTGGGC JP +
1 N6L .G12 GCCTTGTGGG GAAGGGCAG AGAAA J2 +
1 N6L .G13 GCCTTGTGGGAGGTG AGOG ATTATAAGAAA J2 +
1 N6L .G14 GCCTTGTGGGAGGTG CGCGAG ACTGGTTGGTTC JP1 +
1 N6L .G15 GCCTT TAM GATTGGATC JP2 +
1 N6L .G16 GCCTTGT A AM J2 -
Normal 7 19 3 N7L .G1-3 GCCTTGTGGGAGGTG GC GCMGAGTTGGGC JP +
2 N7L .G4-5 GCCTTGTGGGAGGT CCCCTCCCC A J2 +
2 N7L .G6-7 GCCTTGTGGGAGGT CCA GCAAGAGTTGGGC JP +
2 N7L .G8-9 GCCTTGTGGGAGGTG CAAGAGTTGGGC JP +
1 N7L .G10 GCCTTGTGGGAGGTG CA AGTTGGGC JP +
1 N7L .G11 GCCTTGTGGG TTGTCGAC CMGAGTTGGGC JP +
1 N7L .G12 GCCTTGTGGGAGG CA CMGAGTTGGGC JP +
1 N7L .G13 GCCTTGTGGGAGGTG GGG GAGTTGGGC JP +
1 N7L .G14 GCCTTGTGGGAG ACCTCCGGG GAGTTGGGC JP +
1 N7L.G15 GCCTTGTGGGAGGTG GCGGC AGAGTTGGGC JP +
1 N7L .G16 GCCTTGTGGGAGG CGGMGAGC TGGGC JP +
1 N7L .G17 GCCTTGTGGGAGGT AGG GAM J2 +
1 N7L .G18 GC TGCC GGTTGGTTC JP1 +
1 N7L.G19 GCCTTG GAG GAM J2 -
Normal 8 14 2 N8L .G1-2 GCCTTGTGGGAGG CGCAGGGG GAGTTGGGC JP +
2 N8L .G3-4 GCCTTGTGGGAGGTG CAAGAGTTGGGC JP +
2 N8L .G5-6 GCCTTGTGGGAGG CGG AAGAGTTGGGC JP +
1 N8L .G7 GCCTTGTGGG TTGTCGAC CAAGAGTTGGGC JP +
1 N8L .G8 GCCTTGTGGGAGGT TCTT GAGTTGGGC JP +
1 N8L .G9 GCCTTGTGGGAGGT A CMGAGTTGGGC JP +
1 N8L .G10 GCCTTGTGGGAG CCCCGGTTGGG GTTGGGC JP +
1 N8L .G11 GCCTTGTGGGAGG CCAGG GAGTTGGGC JP +
1 N8L .G12 GCCTTGTGGGAGGTG TCMATTATMCAC A J2 +
1 N8L .G13 GCCTTGTGGGAG CCCGGG MTTATTATAAGAM J2 +
1 N8L .G14 GCCTTGTGGGAGG GGAGG AAGAM J2 +
Normal 9 15 6 N9L .G1-6 GCCTTGTGGGAGGTG CG TTATAAGAM J2 +
3 N9L .G7-9 GCCTTGTG CCGGGGGG AGAAA J2 +
2 N9L .G10-11 GCCTTGTGGGAGGT TG TAGTGATTGGATC JP2 +
1 N9L .G12 GCCTTGTGGGAGGTG CCTC ATTATAAGAM J2 +
1 N9L .G13 GCCTTGTGGGAGGTG CAAGAGTTGGGC JP +
1 N9L .G14 GCCTTGTGGG GTACA (TCTTTGG)t J2 -
1 N9L .G15 GCCTTGTGGGAGGTG CGGGAG GAM J2 -a total of 115 Vy9 transcripts from the blood T cells were
sequenced (Table 3). Like the normals, most Vy9 sequences
in blood were in-frame (107 of 115, 93%). However, in con-
trast to normals, there was a dramatic similarity among Vy9
junctional region sequences in a subgroup of these individ-
uals. Two (sarcoids 1 and 2) showed a marked overrepresen-
tation of Vy9 transcripts with the same junctional region
sequence (5'-TGGGAACGGGAAGAGTT3'). In this regard,
for sarcoid 1, 26 of31 clones (84%) shared this sequence (clones
SIB.G1-26), while for sarcoid 2, 15 of 27 clones (56%) had
the identical sequence (clones S2RG1-15). Further, other sar-
coid individuals (sarcoids 3 and 5) also showed three clones
(S3&G1-3) or one done (S5&G1) with the same sequence. The
one sarcoid individual (sarcoid 4) that did not show transcripts
with the samejunctional region sequence had an increase in
number of transcripts with sequences observed in normals
(compare S4B.Gl-5 [5 of 21, 24%] to NIRG7 and N5b.G6
[Table 1]; compare S4B.G6-9 [4 of 21, 19%] to NlRG1-3,
N2B.G1-2, N3RGl-2, N4B.G1-2, N7L.G8-9, N8L.G3-4, and
N9L.G13 [Tables 1 and 2]; as well as other sarcoidosis pa-
tients, SlB.G27-28, and S5RG5 [Table 3]). Most ofVy9 tran-
scripts of blood T cells (100 of 107 clones, 93%) that were
in-frame sequences showeduse ofJ-yP, whilethree clones (3%)
used Jyl and one clone each usedJy2, Jyl, and Jy2. In sar-
coid 1, only two other in-frame sequences were found (other
than the identical sequence previously mentioned), indicating
overall limited diversity of the Vy9 transcripts. In contrast
to sarcoid 1, the other four sarcoidosis individuals showed
large overall diversity in thejunctional region sequences, i.e.,
except the identical sequences described above, the rest of the
transcripts showed different sequences from each other. As
seen in the normal blood, nonproductive Vy9 sequences
among the sarcoid blood T cells mainly used the JyP gene
segment.
The limitation of the availability of the biological material
limited the analysis oflung T cells among the sarcoid individ-
uals. However, for the one individual that couldbe analyzed
(sarcoid 1, the individual with the most dramatic overrepresen-
tation of the sequence 5'-GCCTTGTGGGAACGGG-3' ; see
Table 3), the lung T cells showed the same dramatic over-
representation for this junctional region sequence (Table 4).
In this regard, 14 of the 21 clones (67%, all in-frame) had
the identical sequence. Of the 21 transcripts analyzed, all but
one used the JyP gene segment .
To confirm the presence of a large number of identical Vy9
transcripts in individuals with sarcoidosis compared with
normals, the cDNA populations were evaluated by allele-
specific amplification using a primer specific for thejunctional
region observed in abundance in individuals sarcoid 1 and
2 (Fig. 2). The same Cy primer, PCG5, was used in combi-
nation with either PVG9, a primer for all Vy9 sequences,
or PVNJ9, an allele-specific primer with the specific func-
tional region sequence of the Vy9 gene found in patients
with sarcoidosis clones SIRG1-26, S2B.Gl-15, S3B.G1-3,
S5B.G1, and SIL.Gl-14, and in normal clones N1B.G6 and
N5RG1-2. Consistent with the sequencingdata, dot blot hy-
bridization of amplified cDNA from sarcoid 1 showed al-
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most the same density of the amplified cDNA by the PVNJ9-
PCG5 combination as by the PVG9-PCG5 combination in
both blood (Fig. 2, lanes 1 and 2) and lung (Fig. 2, lanes
3 and 4). Sarcoid 2 showed the same result in the blood (Fig.
2, lanes S and 6) . Sarcoid 4, who did not have any transcripts
with this specific sequence, showed a marked discrepancy in
the density of the total Vy9 transcripts compared with the
junctional region-specific transcripts, consistent with the
finding that thejunctional region-specific sequence must be
rare in this individual (Fig. 2, lanes 7 and 8). Normal indi-
viduals also showed no overrepresentation of this junctional
region-specific sequence (Fig. 2, lanes 9-12) .
V62 mRNA Transcripts in Blood T Cells of Normals.
￿
A
total of 50 V62 transcripts were evaluated in the blood T
cells of three normals (Table 5). Of these, 44 clones (88%)
had in-frame sequences. In the 44 transcripts with in-frame
sequences, 41 clones used J61 (93%), three clones used J63
(7%), while none used J62. All 50 clones showed different
junctional region sequences, suggesting marked diversity.
V62 mRNA Transcripts in Blood T Cells ofIndividuals with
Sarroidosis. For the individuals with sarcoidosis, 84 V62 clones
from four patients were analyzed (Table 6). Of these, 81 clones
(96%) had in-frame sequences. Among the 81 clones with
in-frame sequences, 70 (86%) used J61, 11 (14%) used J63,
and none used J62, the same distribution seen in normals.
In contrast to normal individuals, however, there were sev-
eral sequences that were found in two or more clones. Of
the 28 transcripts sequenced in sarcoid 1, more than half were
overrepresented, with identical sequences observed in seven
clones (25%), six clones (21%), and three clones (11%), respec-
tively, although the sequences of the three sets ofclones were
all different. In sarcoid 2, 10 of 23 clones (43%) showed the
samejunctional sequence, although it was different from that
observed in sarcoid 1. Further, six clones (33%) and three
clones (17%) out of 18 transcripts in sarcoid 3 showed the
samejunctional sequences, respectively, although different from
sarcoid 1 or sarcoid 2.
Although a striking overrepresentation of both Vy9 and
V62 transcripts was observed in several individuals with sar-
coidosis, it was not possible to determine if these over-
represented Vy9 and V62 transcripts were from the same single
T cells. We attempted to answer this question by isolating
single y/6+ T cells from the blood of sarcoid 1, the indivi-
dual with the most marked overrepresentation of sequences
(Tables 3, 4, and 6). Of the 24 cells evaluated at the single
cell level, eight (33%) showed positive amplification of cDNA
using the primers PVG9 and PCG5, the same combination
as described above. However, attempts to sequence the am-
plified cDNAs was unsuccessful, and insufficient biological
material was available to repeat the single-cell sorting and
subsequent analysis.
Discussion
Although there is evidence that the TCRy/6 can initiate
T cell activation and proliferation through recognition of
specific antigens (15-18), the role of y/6 T cells in healthTable 3.
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Sequences shown include the same regions described in Table 1.
' The clones are numbered in the same fashion as described in Table 1; SIB.G1-26, individual with sarcoidosis 1, blood T cells, 'Y chain,






this sequence Clone' V N J
J'v
region In-frame
31 26 S1B.G1-26 GCCTTGTGGGA ACGGG AAGAGTTGGGC JP +
2 SlB .G27-28 GCCTTGTGGGAGGTG CAAGAGTTGGGC JP +
1 SlB .G29 GCCTTGTGG CAAGAGTTGGGC JP +
1 SIB .G30 GCCTTGTGG AATC GAGTTGGGC JP -
1 S1B .G31 GCCTTGTGG AGGT GCAAGAGTTGGGC JP -
27 15 S2B .G1-15 GCCTTGTGGGA ACGGG AAGAGTTGGGC JP +
1 SZB.G16 GCCTTGTGGGAGGTG CGGCG AGAGTTGGGC JP +
1 S2B.G17 GCCTTGTGGGAG TC GCAAGAGTTGGGC JP +
1 S2B.G18 GCCTT ATGGGACCGATG GTTGGGC JP +
1 S2B.G19 GCCTTGTGGGAGGTG CGG GAGTTGGGC JP +
1 S2B.G20 GCCTTGTGGGAGGTG GC GCAAGAGTTGGGC JP +
1 S2B.G21 GCCTTGTGGGAG GGG GAGTTGGGC JP +
1 S2B.G22 GCCTTGTGG CAAGAGTTGGGC JP +
1 S2B .G23 GCCTTGTGGGAGGTG CAAGAGTTGGGC JP +
1 S2B.G24 GCCTTGTGGGAGGTG CAGGC AGAGTTGGGC JP +
1 S2B .G25 GCCTTGTGGGAGGTG TGG GGGCAAGAGTTGGGC JP +
1 S2B .G26 GCCTTGTGGGAGG CCCC GCAAGAGTTGGGC JP +
1 S2B .G27 GCCTTGTGGGAGG GGAGG AAGAAA J2 +
21 3 S3B .G1-3 GCCTTGTGGGA ACGGG AAGAGTTGGGC JP +
1 S3B .G4 GCCTTGTGGGAG TCT CAAGAGTTG= JP +
1 S3B .G5 GCCTTGTGGGAGG CAGGTTTGGG GTTGGGC JP +
1 S3B .G6 GCCTTGTGGGAGG AAGAGTTGGGC JP +
1 S3B .G7 GCCTTGTGGG TGGTGTTAGG AGAGTTGGGC JP +
1 S3B.G8 GCCTTGTGGGA RATA CAAGAGTTGGGC JP +
1 S3B.G9 GCCTTGTGGGAGGTG CT GCAAGAGTTGGGC JP +
1 S3B .G10 GCCTTGTGGGAGG CAG AAGAGTTGGGC JP +
1 S3B .G11 GCCTTGTGGGAGGT CTTAAAT TTGGGC JP +
1 S3B .G12 GCCTTGTGGG TGGCGGTAAG GTTGGGC JP +
1 S3B .G13 GCCTTGTGGGAGGTG CAG GAGTTGGGC JP +
1 S3B .G14 GCCTTGTGGGAG ACCCATGG GTTGGGC JP +
1 S3B .G15 GCCTTGTGGGAGGTG CTGAGT GAGTTGGGC JP +
1 S3B .G16 GCCTTGTGGGAGG C GCAAGAGTTGGGC JP +
1 S3B .G17 GCCTTGTGGGAGGT TAGCTCTCTTTGGGG GTTGGGC JP +
1 S3B .G18 GCCTTGTGGGAGG CGTCGCA GCAAGAGTTGGGC JP +
1 S3B .G19 GCCTTGTGGG GGGGGGT TAAGAAA J1 +
1 S3B .G20 GC TOM GGTTGGTTC JP1 +
1 S3B .G21 GCCTTGTGGGAGGTG CATTTGG GAAA J1 -
21 5 S4B .G1-5 GCCTTGTGGGAGGT AGGC GAGTTGGGC JP +
4 S4B.G6-9 GCCTTGTGGGAGGTG CAAGAGTTGGGC JP +
1 S4BM0 GCCTTGTGGGAGGT AGGCGT GTTGGGC JP +
1 S4B.G11 GCCTTG CGGGAGGCACCTTTGGG GTTGGGC JP +
1 S4B.G12 GCCTTGTGGGAG CAAGAGTTGGGC JP +
1 S4B .G13 GCCTTGTGGGAGG CACCTTTGGG GTTGGGC' JP +
1 S4B.G14 GCCTTGTGGGAGGTG CGG GAGTTGGGC JP +
1 S4B .G15 GCCTTGTGGGAGGTG GG GAGTTGGGC JP +
1 S4BM6 GCCTTGTGGGAGGTG CAG GAGTTGGGC JP +
1 S4B .G17 GCCTTGTGGGA AAGTAGTCGTCCTGT AGAGTTGGGC JP +
1 S4B .G18 GCCTTGTGGGAGGTG CAGGTGGG AGAGTTGGGC JP +
1 S4B .G19 GCCTTGTGGGAGGTG CATGAG GAGTTGGGC JP +
1 S4B .G20 GCCTTGTGGGAGGT CGCCCT TTATTATAAG J1 +
1 SO .= GCCTTGTGGGA ATTTAGCAAGCG CAAGAGTTGGGC JP -
15 1 SUM GCCTTGTGGGA ACGGG AAGAGTTGGGC JP +
1 S5B .G2 GCCTTGTGGGAG AC GCAAGAGTTGGGC JP +
1 S5B .G3 GCCTTGTGGGAGGTG CAG GAGTTGGGC JP +
1 S5B .G4 GCCTTGTGGGAGGTG AAATCG GAGTTGGGC JP +
1 S5B .G5 GCCTTGTGGGAGGTG CAAGAGTTGGGC JP +
1 S5B .G6 GCCTTGTGGGAGGTG CT GCAAGAGTTGGGC JP +
1 S5B .G7 GCCTTGTGGGAG AGCCAAGAGTA GGGC JP +
1 S5B .G8 GCCTTGTGGGAGGTG CGCCGAGAGC TGGGC JP +
1 S5B .G9 GCCTTGTGGGAGG C GCAAGAGTTGGGC JP +
1 S5B .G10 GCCTTGTGGGAGG ATAAGAAA J1 +
1 S5B .G11 GCCTTGTGGGAGGTG GGC AGTGATTGGATC JP2 +
1 S5B .G12 GCCTTGTGGGAGG C CAAGAGTTGGGC JP -
1 S5B .G13 GCCTTGTGGGAGGTG GG AAGAGTTGGGC JP -
1 S5B .G14 GCCTTGTGGGAG ATG CAAGAGTTGGGC JP -
1 S5B,G15 GCCTTG GAG GAAA J2 -Table 4.
￿
.functional Sequences of Vy9-containing mRNA Transcripts in Lung T Cells of an Individual with Sarcoidosis
Individual
Sarcoid 1
Sequences shown include the same regions described in Table 1 .
" The clones are numbered in the same fashion as described in Table 1 ; S1L.Gl-14, individual with sarcoidosis 1, lung T cells, y chain, clones
1-14, etc.
and disease is not well understood . One conceptual problem
in regard to y/S function in antigen recognition relates to
the apparent limited diversity of the number of genetic ele-
ments that can potentially recombine to direct the synthesis
ofy and 6mRNA transcripts (4, 5, 9) . Further, analysis of
blood y/S T cells has shown that the choice ofy and 6 gene
segments that are actually used is limited, with the majority
of y/6 T cells using the Vy9 segment (6-8) . In addition,
most rearranged Vy9 gene segments utilize J-yP and Cyl
elements and pair withVS2 chains (7, 8) . Thus, the specificity
ofTCR-y/b must he elsewhere, likely in thefunctional regions
(N regions) between the V and J (for the y chain) and V
and D, D and D, and D and J (for the 6 chain).
The analysis of 145 Vy9mRNA transcripts and 50 VS2
transcripts from blood and lung of normal individuals in the
present study strongly supports this concept . While there
was clearly limited diversity in the V and J gene segments
used (for Vy9, 86% paired with JyP and 12% with Jy2;
for VS2, 93% paired withJ61), broad diversity was observed
in the junctional regions . In this regard, for the 81 normal
blood Vy9 transcripts, no more than three were identical in
any one individual, and two identical transcripts were ob-
served only six times . For the normal lung, the diversity was
not quite so broad, but still impressive : of 64 Vy9 normal
lung transcripts, 42 different sequences were observed, and
except for six transcripts of one individual that were iden-
tical, lung T cells of other normals had at most only two
or three identical sequences. For the blood VS2 transcripts,
an even broader diversity was observed . Of the 50 transcripts
evaluated, all were different . Further, comparison of the se-
quences ofthe 145 Vy9 and 50V62 transcripts with theVy9
and the VS2 transcripts of T cell clones in the literature re-
vealed no identicaljunctional regions (34-45) . Taken together,
these data support the concept, despite limited genomic diver-
sity, and even further limited actual use of genomic elements
observed in normals, that there is large potential for possible
diverse antigen recognition through the use of the deletion
and addition of junctional sequences .
Although the normal lung showed a broad diversity in
junctional regions forVy9 transcripts, the diversity was some
what less than that observed in blood . Several possibilities
could explain this observation. First, the lungVy9 transcripts
176 Diversity of Vy9 and V62 Junctional Sequences
were from T cells recovered from the pulmonary epithelial
surface, a location that is in contact with the external envi-
ronment, and thus, many antigens i.e., the small increase of
identical transcripts observed among lung T cells, might re-
sult from antigen-driven expansion ofsome y/ST cells within
Figure 2 .
￿
Relative number of total Vy9 transcripts compared with
Vy9 transcripts containing a specific N region (functional region) se-
quence observed in high abundance among Vy9 transcripts of some
individuals with sarcoidosis . Comparisons were made by allele-specific
amplification ofcDNA using Vy9 specific primers and N re-
gion-specific primers. The primer combination of PVG9 and PCG5
was used for total Vy9 amplification (indicated by V above lanes),
while the combination of PVNJ9 and PCG5 was used for N re-
gion-specific amplification (indicated by N above lanes) . Amplified
cDNAs were evaluated by dot blot hybridization with a 32P-labeled
Cy probe (location indicated by closed bar ["probe')) located in Cy
exon I (Cy I) where there is a shared sequence between Cyl and
Cy2. Sarcoids 1, 2, and 4 and normals 1 and 2 ; two correspond to
the individuals thus numbered in the text and tables. Lane 1, Vy9-
specific transcripts in blood of sarcoid 1 ; lane 2, N region-specific
transcripts in blood of sarcoid 1; lane 3, Vy9-specific transcripts in
the lung of sarcoid 1; lane 4, N region-specific transcripts in the
lung of sarcoid 1; lane S, Vy9-specific transcripts in the blood of sar-
coid 2; lane 6, N region-specific transcripts in blood of sarcoid 2;
lane 7, Vy9-specific transcripts in blood of sarcoid 4 ; lane 8, N re-
gion-specific transcripts in blood of sarcoid 4 ; lane 9, Vy9-specific
transcripts in blood of normal 1 ; lane 10, N region-specific tran-
scripts in lung of normal 1; lane 11, Vy9-specific transcripts in blood







this sequence Clone' V N J
Jy
region In-frame
21 14 SlL .G1-14 GCCTTGTGGGA ACGGG AAGAGTTGGGC JP +
2 SIL .G15-16 GCCTTGTGGUGGTG CAAGAGTTGGGC JP +
1 S1L .G17 GCCTTGTGGGAGGTG CAG GAGTTGGGC JP +
1 S1L .G18 GCCT GCTT GCAAGAGTTGGGC JP +
1 S1L .G19 GCCTTGTGGGAGGT CG AAGAGTTGGGC JP +
1 SlL .G20 GCCTTGTGGGAG CAACTGG AAGAGTTGGGC JP +
1 SIL .G21 GCCTTGTGGGAGGT A AAGAAA J2 +Table 5.
￿





the lung. In this context, for other sites exposed to the envi-
ronment, limitedjunctional region diversity has been observed
among y/b T cells in BALB/c mouse skin, although not in
mouse intestinal epithelium (46). It is also relevant, in light
of recent reports of y/6 T cells responding to mycobacterial
antigens, that the lung is a common site for mycobacterial
disease. Second, there is evidence that normal lung T cell
populations differ from blood T cellsin regards to their rela-
tive state of differentiation. For example, -90% of normal




Sequences shown include the 3' region of the V62 element (V), the N region (N-D-N-D-N), the 5' region of the J6 element (J), and the spe-
cific J6 element (16).
" The clones are numbered in the same fashion as described in Table 1; NlB.D1, normal individual 1, blood T cells, 6 chain, clone 1, etc.
UCHL1) (47), a surface antigen observed in antigen-primed
memory T cells, suggestingthat many T cells on the pulmo-
nary epithelial surface have been exposed to specific antigens.
If this is also true for the normal lung y/6 T cell, it would
not be surprising to have less diversity among the lung y/6
population compared with blood.
The broad diversity ofjunctional sequences among Vy9
and V62 transcripts in normals is in marked contrast to the
limited diversity observed in some individuals with sarcoid-






this sequence Clone" V N-D-N-D-N J
J6
region In-frame
19 1 NlB.D1 TGTGACACC CTGGGGGT CACCGATAAA J1 +
1 NlB.D2 TGTGAC GGGGTGGGGGATAGCCGTGG CGATAAA J1 +
1 NlB.D3 TGTGACAC AGTATTAGCTGGGGCCTCAAGGGCGT ACACCGATAAA J1 +
1 NlB.D4 TGTGACACC ATGGCTGTCGGGGGGATAGG CACCGATAAA J1 +
1 NlB.D5 TGTGAC CCCGCAGGTACTGGGGGACCGCAGT ACACCGATAAA J1 +
1 NlB.D6 TGTGACAC TTTGACTACTGGGTTTT ACACCGATAAA J1 +
1 NlB.D7 TGTGACACC TTG( TCGT ACACCGATAAA J1 +
1 NlB.D8 TGTGAC TTACTGGGGGATG AiCACCGATAAA J1 +
1 NlB.D9 TGTGACACC GTTGGGTTTACTTCCTCGT ACACCGATAAA J1 +
1 NlB.D10 TGTGACACC CTGGGGTTAGTCG ACACCGATAAA J1 +
1 NlB.Dll TGTGACA ACTTGCGGGACTGGGGGGTACAGG ACACCGATAAA J1 +
1 NlB.D12 TGTGAC GCTGTACTGG(OGATCCTTCGT ACACCGATAAA J1 +
1 NlB.D13 TGTGACACC GTTGGGGGAATTCAAAGA AAA J1 +
1 NlB.Dl4 TGTGACAC AGTATTAGCTGGGGCCTCAAGGGCGT ACACCGATAAA J1 +
1 NlB.D15 TGTGAC GGCCTGGTACTGGGGGATACGCGTCTAG ACACCGATAAA J1 +
1 NlB.D16 TGTGAC GGTCTGAGGCTGGGGGATACTAGAGGT CCGATAAA J1 -
1 NlB.D17 TGTGACACC GTCGGTCCGGGATACGCGAGGG AAA J1 -
1 NlB.D18 TGTGAC CCCGTTGGGGGATTA ACACCGATAAA J1 -
1 NlB.D19 TGTGACAC GTTGCCGGTCATGiGGAACGT ACACCGATAAA J1 -
16 1 N2B.D1 TGTGACACC CTCCTTACTGGAGGCCCTGTTC CCGATAAA J1 +
1 N2B.D2 TGTGAC CTACTGGGGGAT ACCGATAAA J1 +
1 N2B.D3 TGTGACACC GTCGGGGCCGACCTCC CCGATAAA J1 +
1 N2B.D4 TGTGACAC GCTCCTGGGGGACTCGT ACACCGATAAA Jl +
1 N2B.D5 TGTGA GCCGTTACTGGGGGATAGATCACTCCCG ACACCGATAAA J1 +
1 N2B.D6 TGTGACACC GTGGGACCCGG CACCGATAAA J1 +
1 N2B.D7 TGTGACACC GTCTCTTTGGGGGATAAATCAAGTCGAG CGATAAA J1 +
1 N2B.D8 TGTGACACC GTTGGACAACTGGGGGACG ACACCGATAAA J1 +
1 N2B.D9 TGTGA GGGGATGGGGGATACGG CCGATAAA J1 +
1 N2B.D10 TGTGACACC CTGACTGGGGGATACGTAGTA ACCGATAAA J1 +
1 N2B.D11 TGTGACACC GTTGGGGCCT ACACCGATAAA J1 +
1 N2B.D12 TGTGACAC TCTTACTGGGGGCCCGGGCGG TAAA J1 +
1 N2B.D13 TGTGACACC CTACTGGGGGAGAG CTCCTGGGACA J3 +
1 N2B.D14 TGTGAC CGACTGGGGGATAGGGCCCG CTCCTGGGACA J3 +
1 N2B.D15 TGTGACA GGGTTCCTACGAGACGGGAACTGGGGGAT
ACGAGAACACCGGACATTGCCAAGT ACACCGATAAA J1
1 N2B.D16 TGTGAC CCCTGGGGGTTA ACACCGATAAA J1
15 1 N3B.D1 TGTGAC CCTGCCTTCCTCCGAAGTACTTC CACCGATAAA J1 +
1 N3B.D2 TGTGACACC CTGGGGGTAGTCG ACACCGATAAA J1 +
1 N3B.D3 TGTGA GGCGTTACTGGGGG ACACCGATAAA J1 +
1 N3B.D4 TGTGA TCCCCTCGGGGCGAACGGAGGGATGAC
ACCTC CCGATAAA J1 +
1 N3B.D5 TGTGACACC CTCCCCCGAATGGACTT CACCGATAAA J1 +
1 N3B.D6 TGTGAC CCAGTACTGGGGGATAMCCAMCGGAT ACACCGATAAA J1 +
1 N3B.D7 TGTGAC CACGTACTGGGGGATACGGGGT ACACCGATAAA J1 +
1 N3B.D8 TGTGAC CCTCTAGACAACCC TAM J1 +
1 N3B.D9 TGTGAC TCTTTGGGGGATTTT GATAM J1 +
1 N3B.D10 TGTGAC GCGGTGGGGGAGT ACACCGATAM J1 +
1 N3B.Dll TGTGAC CCAGTACTGGGGGATACGCCACCCGGCT ACACCGATAM J1 +
1 N3B.D12 TGTG TGTCAGTCCGCCTTCCTTCATTTACTGG
GGGATTTGAT ACCGATAM J1 +
1 N3B.D13 TGTGACACC TTAAGGGAA ACCGATAM J1 +
1 N3B.D14 TGTGACAC GGGGAACTGGGGGATAGAG TCCTGGGACA J3 +
1 N3B.D15 TGTGACACC GTGCGTGTCCAAAG CTCCTGGGACA J3 +Table 6.
￿






individuals evaluated, in which 84 and 56% of the Vy9 tran-
scripts in blood were identical, respectively. Further, for one
of these individuals, 67% oflung Vy9 transcripts were iden-
tical and identical to those in blood of the same individual.
Further, for V62 transcripts, for the same two individuals
with sarcoidosis with the striking overrepresentation of specific
Vy9 sequences, there was a marked overrepresentation of
specific V62 sequences. It is likely, therefore, although it cannot
be proven with certainty from the available data, that these
178
￿
Diversity of Vy9 and V62 Junctional Sequences
Sequences shown include the same regions described in Table 5.
The clones are numbered in the same fashion as described in Table 1 ; SlB.D1-7, individual with sarcoidosis 1, blood T cells, 6 chain, clones
1-7, etc.
overrepresented TCR y and 6 chains are present on the same
cell, thereby further limiting TCR diversity. In support of
this concept are the data that: (a) the number ofoverrepresented
sequences is so striking for both Vy9 and V62; (b) the y/6+
cells in these patients are predominantly V61- , and in nor-
mals most y/6 T cells that are V61- are V62+ ; and (c) Vy9
most commonly pairs with V62 in normals (7, 8).
Since the data in this study were developed from RNA






this sequence Clone' V N-D-N-D-N J
J6
region In-frame
28 7 S1BM-7 TGTGAC CCCCTAGAAGGAAACTGGGGAGCCA ACACCGATAAA J1 +
6 SlB.D8-13 TGTGACAC GCTGGGGGATACGGCGT ACACCGATAAA J1 +
3 SM D14-16 TGTGACACC CGTACTGGGGGGTCCCTGT ACACCGATAAA J1 +
2 SIB.D17-18 TGTGACAC TGGOOGGTCCA ACACCGATAAA J1 +
1 S1B.D19 TGTGACAC TACGGTACTGGGGATCGGGTCACCGT ACACCGATAAA J1 +
1 SlB.D20 TGTGACACC CTCGGTATGGGCCTOGGGGATAAGAG CACCGATAAA J1 +
1 SO .= TGTGACAC AACTGGGOGATCTATTT ACACCGATAAA J1 +
1 SlB.D22 TGTGAC TCACTACTGGGGGCGCAC AAA J1 +
1 SlB.D23 TGTGACA GGGGGTGOGACG ACACCGATAAA J1 +
1 SlB.D24 TGTGAC CCCTTACTGGGGGGGATCTCTCTGT ACACCGATAAA J1 +
1 SlB.D25 TGTGAC TTTCTCCGCACTCCGGGACTACGGG ACACCGATAAA J1 +
1 SlB.D26 TGTGAC TCGTTGTCTGGGGCCGCTGC CACCGATAAA J1 +
1 SlB.D27 TGTGACACC GTCGGATCAACGGCCT ATAAA J1 +
1 SlB.D28 TGTGAC CCCAGTACTGGGGGATACTC CTCCTGGGACA J3 +
23 10 S2B.D1-10 TGTGACACC GTGGGGTCCAGACTGGGGATGT ACACCGATAAA J1 +
2 S2B.D11-12 TGTGACACC GTGTCCCGGCTGGGGGATACGG CCGATAAA J1 +
1 S2B.D13 TGTGAC CCCGTACTGGGGGACCGGCTACGGGG CACCGATAAA J1 +
1 S2B.D14 TGTGACACC GTAGGGGGGGATACGCCGAGGT ACACCGATAAA J1 +
1 S2B.D15 TGTGACACC GTGGGGGAAAGCT ACACCGATAAA J1 +
1 S2B.D16 TGTGACACC GTGOGGGGCAAGG CCGATAAA J1 +
1 S2B.D17 TGTGACAC GCTGGOGGATAATG CCGATAAA J1 +
1 SUMS TGTG GCCCTATGGTACTGGGGGATACAGGGG CCGATAAA J1 +
1 S2B.D19 TGTGACAC GGCCCGGAGATTGT ACACCGATAAA J1 +
1 S2B.D20 TGTGAC CCCTTCGTTACGCGTG ACACCGATAAA J1 +
1 S2B.D21 TGTGACACC GTGGCCCGGCTGGGGGATACGG CCGATAAA J1 +
1 S2B.D22 TGTGACAC ACCGGGGGATAG CTCCTGGGACA J3 +
1 S2B.D23 TGTGACACC CCGGGGGATAG CTCCTGGGACA J3 +
18 6 MM-6 TGTG TCGAGCTGGAAAGAGOGGTGGA GGACA J3 +
3 S3B.D7-9 TGTGAC CCAATGGGGGATACGCTCCGTGG A J1 +
1 S3BM0 TGTGACACC GTGGGGGGAT ACACCGATAAA J1 +
1 S3B.D11 TGTGACACC GTTTCAGGGATAAGTCG CACCGATAAA J1 +
1 S3B.D12 TGTGAC CCTATTAGCTACAAACTAATGGGGGAT ACCGATAAA J1 +
1 S3B.D13 TGTGAC CGGOTAOGTACTOGGGGACCCATCCATT ACACCGATAAA J1 +
1 S3B.D14 TGTGAC CTGGTTTCCTCTCATAGTCATACTGGGG
ATTCGT ACACCGATAAA J1 +
1 S3B.D15 TGTGAC CCAGTACTGGGGGATACGCCACCCGGCT ACACCGATAAA J1 +
1 S3B.D16 TGTGACACC GTACTGGGGGATACGGGYsT ACACCGATAAA J1 +
1 S3B.D17 TGTGACACC GTCOGOOGACCTTTAGTT ACCGATAAA JI +
1 SSB.D18 TGTGAC TGTCAGTCCGCCTTCCTTCATTTACTGG
GGGATTTGAT ACCGATAAA J1
15 2 S4BM-2 TGTGAC CCTCTAGACAACCC TAAA J1 +
2 S4B.D3-4 TGTGAC TCGAACTGGGGGATAGGACGT TCCTGGGAGA J3 +
1 S48M TGTGAC CCAGTACTOGOGGATACGCCACCCGGCT ACACCGATAAA J1 +
1 S4B.D6 TGTGAC CCTCTGOCCTGGOOGATATC CACCGATAAA J1 +
1 S4B.D7 TGTGA GAAGATAGGTGTCCGTCGG GATAAA J1 +
1 S4B.D8 TGTGAC TACCTAGGGACAACTTCGT ACACCGATAAA J1 +
1 S4B.D9 TGTGAC CCTCTGGCCTGGGGGATATC CACCGATAAA J1 +
1 S4BM0 TGT TTTCCTCTGGGGGCCC ACACCGATAAA J1 +
1 S4BM1 TGTGA GAAGATAGGTGTCCGTCGG GATAAA J1 +
1 SO .= TGTGACAC AATOGGGGATACGCTCCGTGG A J1 +
1 S4B.D13 TGTGACAC GGTACTGGGGGCCGACCACAG CTCCTGGGACA J3 +
1 S4B.D14 TGTGACAC GCTGGGGGATACGC CACCGATAAA 31 -
1 S4B.D15 TGTGAC CTTTGGGACTCAG CTCCTGGGACA J3 -in interpreting the data is the possibility of an activated sub-
population of the cells having increased numbers of mRNA
transcripts, thereby skewing the results. T cells of theJurkat
tumor cell line activated with PMA have a 5-10-fold increase
in their number of a and ß mRNA transcripts. We have
evaluated this concept in sarcoidosis for the ß chain (48), and
found that in the lung, the numbers of ß chain transcripts
is increased approximately threefold compared with blood,
i.e., in active pulmonary sarcoid it is the lung T cells that
are activated, while the blood T cells are relatively quiescent.
This is consistent with a number of studies comparing lung
and blood T cells in sarcoidosis (49-52). To our knowledge,
no data are available on the level of y and S mRNA tran-
scripts in activated T cells compared with resting T cells,
and there are no data on whether the y/S lymphocytes are
more activated in sarcoidosis patients than in normals. Put-
ting all of the available data together, it is reasonable to con-
clude that the data in our study from blood, showing the
marked overrepresentation of specific Vy9 and VS2 transcripts,
are not associated with an overrepresentation of transcripts
from activated T cells prejudicing the selection for sequencing.
Further, even if the analysis of RNA is taken from sarcoid
patients who have an increased number of activated y/S cells
compared with the normals, and if y and S chain RNA is
increased in this subset ofcells, then, since the stock ofRNA
used for PCR for each patient is a random sample of RNA
extracted from a larger sample of millions of lymphocytes,
the data of overrepresented sequences observed could not be
due to a few-fold increase in transcripts due to activation of
y/S lymphocytes. The ideal way to prove what percentage
of cells have use of the particular y and S transcripts would
be to perform single cell analysis of y and S gene expression.
We attempted this, but could not obtain material after PCR
that could be sequenced.
The implications from the data are interesting for the
emerging concepts regarding the function of the TCRy/S
and for the pathogenesis of sarcoidosis. Most importantly,
put in the setting of studies demonstrating that y/S T cells
play a role in the response to mycobacteria and parasites (13-18),
and can proliferate to mycobacterial proteins, including heat
shock proteins (16-18), it is a reasonable hypothesis that the
y/S T cells in sarcoidosis are being used in a specific, pos-
siblyantigen-driven immune response against such antigens.
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